J.W. Cole Advisors, Inc. Abb Vie Inc. Transaction History

J.W. Cole Advisors, Inc.

$2.33 Billion
Q3 2024

A detailed history of J.W. Cole Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 39,143 shares of ABBV stock, worth $6.87 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

39,143

Previous 36,865 6.18%

Holding current value

$6.87 Million

Previous $6.32 Million 22.24%

% of portfolio

0.33%

Previous 0.3%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$163.84 - $199.33 $373,227 - $454,073	2,278 Added 6.18%	39,143 $7.73 Million
Q2 2024 Aug 08, 2024	BUY	$154.79 - $180.76 $194,106 - $226,673	1,254 Added 3.52%	36,865 $6.32 Million
Q1 2024 Apr 30, 2024	BUY	$159.82 - $182.1 $319 - $364	2 Added 0.01%	35,611 $6.48 Million
Q4 2023 Jan 31, 2024	BUY	$137.6 - $154.97 $1.79 Million - $2.02 Million	13,028 Added 57.69%	35,609 $5.52 Million
Q3 2023 Oct 24, 2023	BUY	$133.59 - $154.65 $288,420 - $333,889	2,159 Added 10.57%	22,581 $3.37 Million
Q2 2023 Jul 27, 2023	SELL	$132.51 - $164.9 $132,510 - $164,900	-1,000 Reduced 4.67%	20,422 $2.75 Million
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $237,883 - $273,958	-1,645 Reduced 7.13%	21,422 $3.41 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $54,770 - $65,684	396 Added 1.75%	23,067 $3.73 Million
Q3 2022 Oct 31, 2022	SELL	$134.21 - $153.93 $310,696 - $356,347	-2,315 Reduced 9.27%	22,671 $3.04 Million
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $1.71 Million - $2.17 Million	-12,419 Reduced 33.2%	24,986 $3.83 Million
Q1 2022 Jun 10, 2022	SELL	$131.98 - $163.75 $353 Million - $438 Million	-2,672,354 Reduced 98.62%	37,405 $6.06 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $353 Million - $437 Million	2,671,492 Added 6981.19%	2,709,759 $3.98 Million
Q4 2021 Jan 25, 2022	BUY	$107.43 - $135.93 $78,209 - $98,957	728 Added 1.94%	38,267 $5.18 Million
Q3 2021 Oct 26, 2021	BUY	$106.4 - $120.78 $156,514 - $177,667	1,471 Added 4.08%	37,539 $4.05 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $250,505 - $279,077	2,381 Added 7.07%	36,068 $4.06 Million
Q1 2021 Apr 28, 2021	BUY	$102.3 - $112.62 $266,286 - $293,149	2,603 Added 8.37%	33,687 $3.65 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $2.01 Million - $2.71 Million	-24,971 Reduced 44.55%	31,084 $3.33 Million
Q3 2020 Nov 05, 2020	BUY	$85.91 - $100.83 $2.38 Million - $2.8 Million	27,726 Added 97.87%	56,055 $4.91 Million
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $1.63 Million - $2.18 Million	22,207 Added 362.74%	28,329 $2.78 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $1.27 Million - $1.92 Million	-19,625 Reduced 76.22%	6,122 $466,000
Q4 2019 Jan 23, 2020	BUY	$72.13 - $90.25 $1.86 Million - $2.32 Million	25,747 New	25,747 $2.28 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.

Account

J.W. Cole Advisors, Inc. Abb Vie Inc. Transaction History